Arterial thrombosis in refractory multiple myeloma patient treated with thalidomide and dexamethasone: A case report

被引：0
|
作者：
Soysal, Dilek [1 ,3 ]
Küçükşahin, Orhan [1 ]
Inci, Ayça [1 ]
Pehlivan, Mustafa [2 ]
机构：
[1] Clinics of 1st Internal Medicine, Atatürk Research Hospital, Izmir, Turkey
[2] Hematology, Atatürk Research Hospital, Izmir, Turkey
[3] Atatürk Research Hospital, First Department of Internal Medicine, Manolya Sokak, No: 44/4, Balçova, Izmir, Turkey
来源：
Turkish Journal of Medical Sciences | 2006年 / 36卷 / 04期
关键词：
9;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：247 / 250
相关论文
共 50 条
  • [31] Thalidomide and thrombosis in patients with multiple myeloma
    Camba, L
    Peccatori, J
    Pescarollo, A
    Tresoldi, M
    Corradini, P
    Bregni, M
    HAEMATOLOGICA, 2001, 86 (10) : 1108 - 1109
  • [32] Thalidomide in refractory and relapsing multiple myeloma
    Bladé, J
    Esteve, J
    Rosiñol, L
    Perales, M
    Montoto, S
    Tuset, M
    Montserrat, E
    SEMINARS IN ONCOLOGY, 2001, 28 (06) : 588 - 592
  • [33] Efficacy and tolerability of combination thalidomide-dexamethasone in multiple myeloma patients with refractory disease
    Hatjiharissi, E
    Gerotziafas, G
    Papaioannou, M
    Bakaloudi, V
    Tokmaktsis, A
    Kaloutsi, V
    Christakis, J
    Zervas, K
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 104 - 104
  • [34] The oral combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is effective in relapsed/refractory multiple myeloma
    R García-Sanz
    J R González-Porras
    J M Hernández
    M Polo-Zarzuela
    A Sureda
    C Barrenetxea
    L Palomera
    R López
    C Grande-García
    A Alegre
    M Vargas-Pabón
    O N Gutiérrez
    J A Rodríguez
    J F San Miguel
    Leukemia, 2004, 18 : 856 - 863
  • [35] The oral combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is effective in relapsed/refractory multiple myeloma
    García-Sanz, R
    González-Porras, JR
    Hernández, JM
    Polo-Zarzuela, M
    Sureda, A
    Barrenetxea, C
    Palomera, L
    López, R
    Grande-García, C
    Alegre, A
    Vargas-Pabón, M
    Gutiérrez, ON
    Rodríguez, JA
    San Miguel, JF
    LEUKEMIA, 2004, 18 (04) : 856 - 863
  • [36] Phase I Trial of the Combination of Lenalidomide, Thalidomide and Dexamethasone In Relapsed/Refractory Multiple Myeloma
    Shah, Jatin J.
    Orlowski, Robert Z.
    Alexanian, Raymond
    Wang, Michael
    Thomas, Sheeba
    Qazilbash, Muzaffar H.
    Parmar, Simrit
    Shah, Nina
    Bashir, Qaiser
    Popat, Uday
    Weber, Donna
    BLOOD, 2010, 116 (21) : 811 - 812
  • [37] Bortezomib in combination with thalidomide and dexamethasone - a successful treatment regimen in refractory extramedullary multiple myeloma
    Dytfeld, Dominik
    Matuszak, Magdalena
    Lewandowski, Krzysztof
    Komarnicki, Mieczyslaw
    ANNALS OF HEMATOLOGY, 2008, 87 (03) : 253 - 254
  • [38] Bortezomib in combination with thalidomide and dexamethasone—a successful treatment regimen in refractory extramedullary multiple myeloma
    Dominik Dytfeld
    Magdalena Matuszak
    Krzysztof Lewandowski
    Mieczysław Komarnicki
    Annals of Hematology, 2008, 87 : 253 - 254
  • [39] Thalidomide with dexamethasone for resistant multiple myeloma.
    Weber, DM
    Rankin, K
    Gavino, M
    Delasalle, K
    Alexanian, R
    BLOOD, 2000, 96 (11) : 167A - 167A
  • [40] Thalidomide alone or with dexamethasone for multiple myeloma.
    Weber, DM
    Gavino, M
    Delasalle, K
    Rankin, K
    Giralt, S
    Alexanian, R
    BLOOD, 1999, 94 (10) : 604A - 604A
12345